Roivant Sciences Ltd.
Reporting owner on Forms 3, 4 and 5, CIK 1635088.
Roivant Sciences Ltd. reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Arbutus Biopharma Corp CIK 1447028 | director, 10% owner | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp Common Shares | 2026-10-01 | D returned to the issuer | -8,967,383 | $5 | 29,880,079 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D/A 0001140361-26-038693 | ABUS | 2026-10-05 | ||
| Form 4 0001140361-26-038692 | Arbutus Biopharma Corp | 2026-10-05 |